Co-Authors
This is a "connection" page, showing publications co-authored by Lawrence Kushi and Candyce Kroenke.
Connection Strength
3.043
-
Personal and clinical social support and adherence to adjuvant endocrine therapy among hormone receptor-positive breast cancer patients in an integrated health care system. Breast Cancer Res Treat. 2018 Aug; 170(3):623-631.
Score: 0.645
-
Social networks, social support mechanisms, and quality of life after breast cancer diagnosis. Breast Cancer Res Treat. 2013 Jun; 139(2):515-27.
Score: 0.458
-
A validation study for measuring Asian- and Hispanic-serving sociocultural institutions in neighborhoods using business listing data and potential implications for health. Soc Sci Med. 2024 Jul 17; 356:117143.
Score: 0.249
-
Differences in Smoking Behavior by Nativity, Race/Ethnicity, and Education Among Women Diagnosed with Breast Cancer. Cancer Epidemiol Biomarkers Prev. 2024 Feb 12.
Score: 0.241
-
Individual- and neighborhood-level socioeconomic status and risk of aggressive breast cancer subtypes in a pooled cohort of women from Kaiser Permanente Northern California. Cancer. 2021 Aug 20.
Score: 0.203
-
Clustering of Social and Physical Pain Variables and Their Association With Mortality in Two Population-Based Cohorts. Psychosom Med. 2021 04 01; 83(3):228-238.
Score: 0.198
-
"I Had to Make Them Feel at Ease": Narrative Accounts of How Women With Breast Cancer Navigate Social Support. Qual Health Res. 2021 05; 31(6):1056-1068.
Score: 0.197
-
Representativeness of breast cancer cases in an integrated health care delivery system. BMC Cancer. 2015 Oct 14; 15:688.
Score: 0.136
-
Race and breast cancer survival by intrinsic subtype based on PAM50 gene expression. Breast Cancer Res Treat. 2014 Apr; 144(3):689-99.
Score: 0.121
-
Patient characteristics associated with intended non-guideline chemotherapy in women with stage I-IIIA breast cancer. Cancer Epidemiol Biomarkers Prev. 2024 Jul 25.
Score: 0.062
-
Patient characteristics associated with delayed time to adjuvant chemotherapy among women treated for stage I-IIIA breast cancer. Int J Cancer. 2024 Jul 06.
Score: 0.062
-
Trends in chemotherapy use for early-stage breast cancer from 2006 to 2019. Breast Cancer Res. 2024 Jun 13; 26(1):101.
Score: 0.062
-
Methodology for Using Real-World Data From Electronic Health Records to Assess Chemotherapy Administration in Women With Breast Cancer. JCO Clin Cancer Inform. 2024 Apr; 8:e2300209.
Score: 0.061
-
Evaluation of algorithms using automated health plan data to identify breast cancer recurrences. Cancer Epidemiol Biomarkers Prev. 2023 Dec 13.
Score: 0.060
-
Impact of Racial/Ethnic Discrimination on Quality of Life among Breast Cancer Survivors: The Pathways Study. Am J Epidemiol. 2022 Dec 01.
Score: 0.056
-
Impact of Social and Built Environment Factors on Body Size among Breast Cancer Survivors: The Pathways Study. Cancer Epidemiol Biomarkers Prev. 2017 04; 26(4):505-515.
Score: 0.037
-
Exercise and Prognosis on the Basis of Clinicopathologic and Molecular Features in Early-Stage Breast Cancer: The LACE and Pathways Studies. Cancer Res. 2016 09 15; 76(18):5415-22.
Score: 0.036
-
Exercise and Risk of Cardiovascular Events in Women With Nonmetastatic Breast Cancer. J Clin Oncol. 2016 08 10; 34(23):2743-9.
Score: 0.035
-
Breastfeeding, PAM50 tumor subtype, and breast cancer prognosis and survival. J Natl Cancer Inst. 2015 Jul; 107(7).
Score: 0.033
-
Association of high obesity with PAM50 breast cancer intrinsic subtypes and gene expression. BMC Cancer. 2015 Apr 14; 15:278.
Score: 0.033
-
Intrinsic subtypes from the PAM50 gene expression assay in a population-based breast cancer survivor cohort: prognostication of short- and long-term outcomes. Cancer Epidemiol Biomarkers Prev. 2014 May; 23(5):725-34.
Score: 0.030
-
Racial disparities in posttraumatic stress after diagnosis of localized breast cancer: the BQUAL study. J Natl Cancer Inst. 2013 Apr 17; 105(8):563-72.
Score: 0.028